F-1/A: U-BX Technology Ltd. Files Amendment No. 18 to Form F-1 for Initial Public Offering

U-BX Technology Ltd. is proceeding with its initial public offering of ordinary shares, aiming to list on the Nasdaq Capital Market under the symbol UBXG.

Summary

• U-BX Technology Ltd., a Cayman Islands-based holding company, has filed Amendment No. 18 to its Form F-1 registration statement for an initial public offering (IPO).
• The company plans to offer 2,000,000 ordinary shares at an expected price of $5.00 per share.
• U-BX Technology Ltd. intends to list its ordinary shares on the Nasdaq Capital Market under the ticker symbol UBXG, contingent upon approval.
• The company conducts its operations in China through its subsidiaries, focusing on providing AI-driven technology services to the insurance industry.
• The IPO is subject to certain risks, including those related to doing business in China and the Holding Foreign Companies Accountable Act (HFCA Act).
• EF Hutton LLC is serving as the book-running manager for the offering.
• The company has completed the record filing requirement with the CSRC on September 25, 2023.

Sentiment

Score: 6

Explanation: The document is primarily factual and descriptive, outlining the terms of the IPO and associated risks. The sentiment is neutral, with a slight positive leaning due to the progress made in the IPO process.

Positives

• The company has completed the record filing requirement with the CSRC on September 25, 2023.
• The company's auditor, Wei, Wei & Co., LLP, is PCAOB inspected.
• The company's 'Magic Mirror' algorithm provides a unique risk assessment service for auto insurance carriers.

Negatives

• The company faces legal and operational risks associated with having substantially all business operations in China.
• The company is subject to the filing requirements of the CSRC for this offering under the Trial Measures.
• The company's ordinary shares may be prohibited from trading on a national exchange under the Holding Foreign Companies Accountable Act (the HFCA Act) if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect our auditors for two consecutive years beginning in 2021.

Risks

• Changes in Chinese legal, political, and economic policies could adversely affect the company's business.
• PRC laws and regulations governing the company's business operations are sometimes vague and uncertain.
• The approval of the CSRC may be required in connection with this offering, and there is no guarantee such approval will be obtained.
• The company's ordinary shares may be prohibited from trading on a national exchange under the Holding Foreign Companies Accountable Act (the HFCA Act) if the Public Company Accounting Oversight Board (the PCAOB) is unable to inspect our auditors for two consecutive years beginning in 2021.
• As a holding company, U-BX may rely on dividends and other distributions on equity paid by our subsidiaries for our cash and financing requirements.

Future Outlook

The company expects to have a broader reach within the overall insurance industry, as its business focuses on providing insurance technology solutions to insurance carriers interested in applying artificial intelligence technology and online traffic promotion method in their operation.

Industry Context

The company operates in the insurance technology industry, providing AI-driven technology services to insurance carriers and brokers in China. The industry is subject to regulatory changes and competition.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards or competitors.
• The document mentions that the company's major competitors are mainly involved in helping insurance carriers acquire more clients or with insurance carriers policy issuing process, whereas the company relies on internet technology and online traffic promotions.

Stakeholder Impact

• Shareholders will be subject to the risks associated with investing in a company with significant operations in China.
• Shareholders may experience dilution of their holdings due to the issuance of new shares in the IPO.
• The company's ability to execute its business plan will impact the value of shareholders' investments.

Next Steps

• Obtain approval for listing on the Nasdaq Capital Market.
• Complete the sale of ordinary shares in the IPO.
• Remit the net proceeds to China.
• Implement the intended use of proceeds for research and development, advertising and marketing, and general working capital.

Key Dates

Keywords

IPO, ordinary shares, U-BX Technology, CSRC, HFCA Act, PCAOB, China, insurance technology, EF Hutton, Nasdaq